NRx Pharmaceuticals, Inc. logo

NRx Pharmaceuticals, Inc.


Overview | Financials
Company Name NRx Pharmaceuticals, Inc.
Symbol NRXP
Currency USD
Price 3.03
Market Cap 32,422,845
Dividend Yield 0%
52-week-range 1.9 - 7.33
Industry Biotechnology
Sector Healthcare
CEO Mr. Stephen H. Willard Esq.

An error occurred while fetching data.

About NRx Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the

Related Stocks

Evelo Biosciences, Inc. logo

Evelo Biosciences, Inc.


0.06 USD

Elevation Oncology, Inc. logo

Elevation Oncology, Inc.


3.23 USD

Passage Bio, Inc. logo

Passage Bio, Inc.


1.05 USD

Daré Bioscience, Inc. logo

Daré Bioscience, Inc.


0.45 USD


Numbers are in millions USD

Numbers are in millions USD